Tumori
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.0 | Q4 | 25.2% | 0.574 | Q2 | 66.0% |
| 2024 | 3.1 | Q2 | 57.1% | 0.535 | Q2 | 64.5% |
| 2023 | 2.0 | Q3 | 31.7% | 0.466 | Q3 | 62.6% |
| 2022 | 1.9 | Q4 | 21.7% | 0.443 | Q3 | 62.5% |
| 2021 | 2.1 | Q4 | 31.9% | 0.407 | Q3 | 60.8% |
| 2020 | — | — | 0.453 | Q3 | 63.3% | |
| 2019 | — | — | 0.412 | Q3 | 61.9% | |
| 2018 | — | — | 0.381 | Q3 | 57.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2038-2529
ISSN
0300-8916
country
ITcoverage
1946-2026